loadpatents
name:-0.026962041854858
name:-0.020052909851074
name:-0.022068977355957
BioMarin Technologies B.V. Patent Filings

BioMarin Technologies B.V.

Patent Applications and Registrations

Patent applications and USPTO patent grants for BioMarin Technologies B.V..The latest application filed is for "oligonucleotide".

Company Profile
23.26.26
  • BioMarin Technologies B.V. - Leiden N/A NL
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Methods and means for efficient skipping of exon 45 in Duchenne muscular dystrophy pre-mRNA
Grant 11,427,820 - De Kimpe , et al. August 30, 2
2022-08-30
Oligonucleotide
App 20220098586 - de Visser; Peter Christian ;   et al.
2022-03-31
Methods and means for treating DNA repeat instability associated genetic disorders
Grant 11,274,299 - De Kimpe , et al. March 15, 2
2022-03-15
Bispecific Antisense Oligonucleotides For Dystrophin Exon Skipping
App 20220025368 - van Deutekom; Judith Christina Theodora ;   et al.
2022-01-27
Oligonucleotide Comprising An Inosine For Treating Dmd
App 20210254071 - van Deutekom; Judith Christina Theodora ;   et al.
2021-08-19
Method For Efficient Exon (44) Skipping In Duchenne Muscular Dystrophy And Associated Means
App 20210207138 - Platenburg; Gerard Johannes ;   et al.
2021-07-08
Oligonucleotide comprising an inosine for treating DMD
Grant 11,034,956 - Van Deutekom , et al. June 15, 2
2021-06-15
Methods And Means For Efficient Skipping Of At Least One Of The Following Exons Of The Human Duchenne Muscular Dystrophy Gene: 43, 46, 50-53
App 20210139904 - Van Deutekom; Judith Christina Theodora
2021-05-13
RNA Modulating Oligonucleotides with Improved Characteristics for the Treatment of Duchenne and Becker Muscular Dystrophy
App 20210108204 - de Visser; Peter Christian ;   et al.
2021-04-15
Means and methods for counteracting muscle disorders
Grant RE48,468 - De Kimpe , et al. March 16, 2
2021-03-16
RNA modulating oligonucleotides with improved characteristics for the treatment of Duchenne and Becker muscular dystrophy
Grant 10,913,946 - de Visser , et al. February 9, 2
2021-02-09
Methods and means for efficient skipping of at least one of the following exons of the human Duchenne muscular dystrophy gene: 43, 46, 50-53
Grant 10,876,114 - Van Deutekom December 29, 2
2020-12-29
Oligonucleotide Comprising An Inosine For Treating Dmd
App 20200291399 - Van Deutekom; Judith Christina Theodora ;   et al.
2020-09-17
METHODS AND MEANS FOR EFFICIENT SKIPPING OF EXON 45 IN DUCHENNE MUSCULAR DYSTROPHY PRE-mRNA
App 20200239886A1 -
2020-07-30
Treatment of genetic disorders associated with DNA repeat instability
Grant 10,689,646 - De Kimpe , et al.
2020-06-23
Rna Modulating Oligonucleotides With Improved Characteristics For The Treatment Of Neuromuscular Disorders
App 20200149043 - DE VISSER; Peter Christian ;   et al.
2020-05-14
Methods and means for treating DNA repeat instability associated genetic disorders
App 20200140857 - DE KIMPE; Josephus Johannes ;   et al.
2020-05-07
Oligonucleotide comprising an inosine for treating DMD
Grant 10,533,171 - Van Deutekom , et al. Ja
2020-01-14
Method For Efficient Exon (44) Skipping In Duchenne Muscular Dystrophy And Associated Means
App 20190292541 - Platenburg; Gerard Johannes ;   et al.
2019-09-26
RNA Modulating Oligonucleotides with Improved Characteristics for the Treatment of Duchenne and Becker Muscular Dystrophy
App 20190194656 - de Visser; Peter Christian ;   et al.
2019-06-27
METHODS AND MEANS FOR EFFICIENT SKIPPING OF EXON 45 IN DUCHENNE MUSCULAR DYSTROPHY PRE-mRNA
App 20190177725 - De Kimpe; Josephus Johannes ;   et al.
2019-06-13
METHODS AND MEANS FOR EFFICIENT SKIPPING OF EXON 45 IN DUCHENNE MUSCULAR DYSTROPHY PRE-mRNA
App 20190119679 - De Kimpe; Josephus Johannes ;   et al.
2019-04-25
METHODS AND MEANS FOR EFFICIENT SKIPPING OF EXON 45 IN DUCHENNE MUSCULAR DYSTROPHY PRE-mRNA
App 20190112604 - De Kimpe; Josephus Johannes ;   et al.
2019-04-18
Methods And Means For Efficient Skipping Of At Least One Of The Following Exons Of The Human Duchenne Muscular Dystrophy Gene: 43, 46, 50-53
App 20190100754 - Van Deutekom; Judith Christina Theodora
2019-04-04
Method for efficient exon (44) skipping in duchenne muscular dystrophy and associated means
Grant 10,246,707 - Platenburg , et al.
2019-04-02
RNA modulating oligonucleotides with improved characteristics for the treatment of duchenne and becker muscular dystrophy
Grant 10,179,912 - de Visser , et al. Ja
2019-01-15
RNA Modulating Oligonucleotides with Improved Characteristics for the Treatment of Duchenne and Becker Muscular Dystrophy
App 20180362973 - de Visser; Peter Christian ;   et al.
2018-12-20
Treatment Of Genetic Disorders Associated With DNA Repeat Instability
App 20180112214 - De KIMPE; Josephus Johannes ;   et al.
2018-04-26
Methods and means for efficient skipping of exon 45 in Duchenne muscular dystrophy pre-mRNA
Grant 9,926,557 - De Kimpe , et al. March 27, 2
2018-03-27
RNA Modulating Oligonucleotides with Improved Characteristics for the Treatment of Neuromuscular Disorders
App 20180066256 - de Visser; Peter Christian ;   et al.
2018-03-08
Treatment of genetic disorders associated with DNA repeat instability
Grant 9,890,379 - De Kimpe , et al. February 13, 2
2018-02-13
Oligomers Having Bicyclic Scaffold Moeities
App 20180028554 - Van DEUTEKOM; Judith Christina Theodora ;   et al.
2018-02-01
RNA modulating oligonucleotides with improved characteristics for the treatment of neuromuscular disorders
Grant 9,745,576 - de Visser , et al. August 29, 2
2017-08-29
Oligonucleotide Comprising An Inosine For Treating Dmd
App 20170204414 - Van DEUTEKOM; Judith Christina Theodora ;   et al.
2017-07-20
METHODS AND MEANS FOR EFFICIENT SKIPPING OF EXON 45 IN DUCHENNE MUSCULAR DYSTROPHY PRE-mRNA
App 20170107512 - De KIMPE; Josephus Johannes ;   et al.
2017-04-20
Methods And Means For Efficient Skipping Of At Least One Of The Following Exons Of The Human Duchenne Muscular Dystrophy Gene: 43, 46, 50-53
App 20170044534 - Van DEUTEKOM; Judith Christina Theodora
2017-02-16
RNA Modulating Oligonucleotides with Improved Characteristics for the Treatment of Duchenne and Becker Muscular Dystrophy
App 20170029818 - de Visser; Peter Christian ;   et al.
2017-02-02
Compounds For Treating, Delaying And/or Preventing A Human Genetic Disorder Such As Myotonic Dystrophy Type I (dmi)
App 20170029820 - Aguilera Diez; Maria Begona ;   et al.
2017-02-02
Methods and means for efficient skipping of exon 45 in duchenne muscular dystrophy pre-mRNA
Grant 9,528,109 - De Kimpe , et al. December 27, 2
2016-12-27
Methods and means for efficient skipping of at least one of the exons 51-53, 55, 57 and 59 of the human duchenne muscular dystrophy gene
Grant 9,499,818 - van Deutekom November 22, 2
2016-11-22
Means And Methods For Counteracting Muscle Disorders
App 20160304864 - De KIMPE; Josephus Johannes ;   et al.
2016-10-20
Oligonucleotide Comprising An Inosine For Treating Dmd
App 20160264967 - Van DEUTEKOM; Judith Christina Theodora ;   et al.
2016-09-15
Means and methods for counteracting muscle disorders
Grant 9,243,245 - De Kimpe , et al. January 26, 2
2016-01-26

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed